Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1990;17(3):165–172.

After Thrombolytic Therapy

Angiography, Angioplasty, or Surgery?

Michael L Stadius 1
PMCID: PMC324913  PMID: 15227167

Abstract

Thrombolytic therapy has been found to improve the prognosis of selected patients with acute myocardial infarction. Many investigators advocate that combined emergency coronary angiography and percutaneous transluminal coronary angioplasty be performed immediately after thrombolytic therapy. Emergency angiography documents the anatomic extent of coronary artery disease, shows whether reperfusion has occurred, and indicates whether emergency angioplasty is necessary. In this setting, emergency catheterization without angioplasty is associated with relatively little additional risk. However, a number of prospective trials have compared emergency angioplasty to more conservative treatment strategies, and emergency angioplasty has been not found to offer any advantage in terms of improved prognosis or preservation of left ventricular function. Therefore, it is probable that most patients with evolving Q-wave myocardial infarction are best treated with conservative strategies after initial thrombolytic therapy, although there may still be a role for emergency angioplasty in a relatively small subset who present with evolving myocardial infarction and severely depressed left ventricular function.

Emergency coronary artery bypass surgery also appears to have a limited role in patients treated with thrombolytic therapy. Nevertheless, in occasional patients with a poor prognosis at hospital presentation, in whom thrombolytic therapy and emergency angioplasty have failed or are contraindicated, prompt emergency coronary artery bypass grafting may salvage the ischemic myocardium and improve the prognosis. (Texas Heart Institute Journal 1990;17:165-72)

Keywords: Angiography

Keywords: angioplasty, transluminal

Keywords: clinical trials

Keywords: combined modality therapy

Keywords: coronary circulation

Keywords: fibrinolytic agents

Keywords: myocardial infarction

Keywords: plasminogen activator, tissue type

Keywords: streptokinase

Full text

PDF
165

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L., Marshall H. W., Bray B. E., Lutz J. R., Frederick P. R., Yanowitz F. G., Datz F. L., Klausner S. C., Hagan A. D. A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med. 1983 Jun 2;308(22):1312–1318. doi: 10.1056/NEJM198306023082202. [DOI] [PubMed] [Google Scholar]
  2. Berg R., Jr, Selinger S. L., Leonard J. J., Coleman W. S., DeWood M. Acute evolving myocardial infarction. A surgical emergency. J Thorac Cardiovasc Surg. 1984 Nov;88(5 Pt 2):902–906. [PubMed] [Google Scholar]
  3. DeWood M. A., Spores J., Notske R., Mouser L. T., Burroughs R., Golden M. S., Lang H. T. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980 Oct 16;303(16):897–902. doi: 10.1056/NEJM198010163031601. [DOI] [PubMed] [Google Scholar]
  4. Hartzler G. O., Rutherford B. D., McConahay D. R., Johnson W. L., Jr, McCallister B. D., Gura G. M., Jr, Conn R. C., Crockett J. E. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J. 1983 Nov;106(5 Pt 1):965–973. doi: 10.1016/0002-8703(83)90639-7. [DOI] [PubMed] [Google Scholar]
  5. Kennedy J. W., Ritchie J. L., Davis K. B., Fritz J. K. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med. 1983 Dec 15;309(24):1477–1482. doi: 10.1056/NEJM198312153092402. [DOI] [PubMed] [Google Scholar]
  6. Kennedy J. W., Ritchie J. L., Davis K. B., Stadius M. L., Maynard C., Fritz J. K. The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report. N Engl J Med. 1985 Apr 25;312(17):1073–1078. doi: 10.1056/NEJM198504253121701. [DOI] [PubMed] [Google Scholar]
  7. Kereiakes D. J., Topol E. J., George B. S., Abbottsmith C. W., Stack R. S., Candela R. J., O'Neill W. W., Martin L. H., Califf R. M. Emergency coronary artery bypass surgery preserves global and regional left ventricular function after intravenous tissue plasminogen activator therapy for acute myocardial infarction. J Am Coll Cardiol. 1988 May;11(5):899–907. doi: 10.1016/s0735-1097(98)90043-2. [DOI] [PubMed] [Google Scholar]
  8. Khaja F., Walton J. A., Jr, Brymer J. F., Lo E., Osterberger L., O'Neill W. W., Colfer H. T., Weiss R., Lee T., Kurian T. Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med. 1983 Jun 2;308(22):1305–1311. doi: 10.1056/NEJM198306023082201. [DOI] [PubMed] [Google Scholar]
  9. Leiboff R. H., Katz R. J., Wasserman A. G., Bren G. B., Schwartz H., Varghese P. J., Ross A. M. A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction. Am J Cardiol. 1984 Feb 1;53(4):404–407. doi: 10.1016/0002-9149(84)90002-x. [DOI] [PubMed] [Google Scholar]
  10. Meyer J., Merx W., Schmitz H., Erbel R., Kiesslich T., Dörr R., Lambertz H., Bethge C., Krebs W., Bardos P. Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation. 1982 Nov;66(5):905–913. doi: 10.1161/01.cir.66.5.905. [DOI] [PubMed] [Google Scholar]
  11. O'Neill W., Timmis G. C., Bourdillon P. D., Lai P., Ganghadarhan V., Walton J., Jr, Ramos R., Laufer N., Gordon S., Schork M. A. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med. 1986 Mar 27;314(13):812–818. doi: 10.1056/NEJM198603273141303. [DOI] [PubMed] [Google Scholar]
  12. Phillips S. J., Zeff R. H., Skinner J. R., Toon R. S., Grignon A., Kongtahworn C. Reperfusion protocol and results in 738 patients with evolving myocardial infarction. Ann Thorac Surg. 1986 Feb;41(2):119–125. doi: 10.1016/s0003-4975(10)62650-1. [DOI] [PubMed] [Google Scholar]
  13. Pifarré R., Spinazzola A., Nemickas R., Scanlon P. J., Tobin J. R. Emergency aortocoronary bypass for acute myocardial infarction. Arch Surg. 1971 Nov;103(5):525–528. doi: 10.1001/archsurg.1971.01350110023002. [DOI] [PubMed] [Google Scholar]
  14. Rentrop P., Blanke H., Karsch K. R., Kaiser H., Köstering H., Leitz K. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation. 1981 Feb;63(2):307–317. doi: 10.1161/01.cir.63.2.307. [DOI] [PubMed] [Google Scholar]
  15. Simoons M. L., Arnold A. E., Betriu A., de Bono D. P., Col J., Dougherty F. C., von Essen R., Lambertz H., Lubsen J., Meier B. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet. 1988 Jan 30;1(8579):197–203. doi: 10.1016/s0140-6736(88)91062-8. [DOI] [PubMed] [Google Scholar]
  16. Simoons M. L., Serruys P. W., vd Brand M., Bär F., de Zwaan C., Res J., Verheugt F. W., Krauss X. H., Remme W. J., Vermeer F. Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet. 1985 Sep 14;2(8455):578–582. doi: 10.1016/s0140-6736(85)90584-7. [DOI] [PubMed] [Google Scholar]
  17. Stack R. S., Califf R. M., Hinohara T., Phillips H. R., Pryor D. B., Simonton C. A., Carlson E. B., Morris K. G., Behar V. S., Kong Y. Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1988 Jun;11(6):1141–1149. doi: 10.1016/0735-1097(88)90274-4. [DOI] [PubMed] [Google Scholar]
  18. Stadius M. L., Davis K., Maynard C., Ritchie J. L., Kennedy J. W. Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. The Western Washington Intracoronary Streptokinase Trial. Circulation. 1986 Oct;74(4):703–711. doi: 10.1161/01.cir.74.4.703. [DOI] [PubMed] [Google Scholar]
  19. Stein B., Fuster V., Israel D. H., Cohen M., Badimon L., Badimon J. J., Chesebro J. H. Platelet inhibitor agents in cardiovascular disease: an update. J Am Coll Cardiol. 1989 Oct;14(4):813–836. doi: 10.1016/0735-1097(89)90453-1. [DOI] [PubMed] [Google Scholar]
  20. Topol E. J., Califf R. M., George B. S., Kereiakes D. J., Abbottsmith C. W., Candela R. J., Lee K. L., Pitt B., Stack R. S., O'Neill W. W. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 1987 Sep 3;317(10):581–588. doi: 10.1056/NEJM198709033171001. [DOI] [PubMed] [Google Scholar]
  21. Topol E. J., Califf R. M., George B. S., Kereiakes D. J., Rothbaum D., Candela R. J., Abbotsmith C. W., Pinkerton C. A., Stump D. C., Collen D. Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction. Circulation. 1988 May;77(5):1100–1107. doi: 10.1161/01.cir.77.5.1100. [DOI] [PubMed] [Google Scholar]
  22. Van de Werf F., Ludbrook P. A., Bergmann S. R., Tiefenbrunn A. J., Fox K. A., de Geest H., Verstraete M., Collen D., Sobel B. E. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. N Engl J Med. 1984 Mar 8;310(10):609–613. doi: 10.1056/NEJM198403083101001. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES